missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Human BCMA/TNFRSF17 Antibody, R&D Systems™

Mouse Monoclonal Antibody
201.00 € - 454.00 €
Specifications
| Antigen | BCMA/TNFRSF17 |
|---|---|
| Clone | 1039701 |
| Dilution | Flow Cytometry 0.25 ug/106 cells |
| Applications | Flow Cytometry |
| Classification | Monoclonal |
| Product Code | Brand | Quantity | Price | Quantity & Availability | |||||
|---|---|---|---|---|---|---|---|---|---|
| Product Code | Brand | Quantity | Price | Quantity & Availability | |||||
18703797
![]() |
R&D Systems
MAB1933-SP |
25 μg |
201.00 €
25µg |
Please sign in to purchase this item. Need a web account? Register with us today! | |||||
18754657
![]() |
R&D Systems
MAB1933-100 |
100 μg |
454.00 €
100µg |
Please sign in to purchase this item. Need a web account? Register with us today! | |||||
Description
BCMA/TNFRSF17 Monoclonal antibody specifically detects BCMA/TNFRSF17 in Human samples. It is validated for Flow CytometrySpecifications
| BCMA/TNFRSF17 | |
| Flow Cytometry 0.25 ug/106 cells | |
| Monoclonal | |
| Purified | |
| RUO | |
| Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS. | |
| B cell maturation antigen, B-cell maturation protein, BCMAtumor necrosis factor receptor superfamily member 17, BCMB-cell maturation factor, CD269, CD269 antigen, TNFRSF13A, TNFRSF17, tumor necrosis factor receptor superfamily, member 17 | |
| Mouse myeloma cell line NS0-derived recombinant human BCMA/TNFRSF17, Met1-Ala54, Accession # Q02223 | |
| Primary | |
| Reconstitute at 0.5 mg/mL in sterile PBS. |
| 1039701 | |
| Flow Cytometry | |
| Unconjugated | |
| Mouse | |
| Human | |
| Q02223 | |
| 608 | |
| IgG1 | |
| Protein A or G purified from hybridoma culture supernatant | |
| Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70°C as supplied. 1 month, 2 to 8°C under sterile conditions after reconstitution. 6 months, -20 to -70°C under sterile conditions after reconstitution. |
Spot an opportunity for improvement?Share a Content Correction
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title